Home

Hviske hagl Ære news teva pharmaceuticals smør Såvel Gennemvæd

Articles with Teva Pharmaceuticals, Inc.
Articles with Teva Pharmaceuticals, Inc.

US states sue Teva for price-fixing in 'multi-billion dollar fraud' | The  Times of Israel
US states sue Teva for price-fixing in 'multi-billion dollar fraud' | The Times of Israel

Teva Pharmaceuticals Found Liable in Landmark Opioid Trial - The New York  Times
Teva Pharmaceuticals Found Liable in Landmark Opioid Trial - The New York Times

Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva Pharmaceuticals found liable in New York opioid trial - BBC News

Teva: Reportedly Planning Thousands of Layoffs in the U.S. | Fortune
Teva: Reportedly Planning Thousands of Layoffs in the U.S. | Fortune

Teva Pharma Appoints Novartis, Biogen Vet as New President and CEO |  BioSpace
Teva Pharma Appoints Novartis, Biogen Vet as New President and CEO | BioSpace

Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceuticals is found liable in the opioid crisis : NPR

Teva to settle opioid-related claims in Florida for $117 million | The  Times of Israel
Teva to settle opioid-related claims in Florida for $117 million | The Times of Israel

Teva Pharmaceuticals, News And Latest Headlines - I24NEWS
Teva Pharmaceuticals, News And Latest Headlines - I24NEWS

teva News and latest stories | The Jerusalem Post
teva News and latest stories | The Jerusalem Post

Teva Announces FDA Approval of AUSTEDO® XR (deutetrabenazine)  Extended-Release Tablets, a New Once-Daily Formulation of AUSTEDO®  (deutetrabenazine) Tablets | Business Wire
Teva Announces FDA Approval of AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, a New Once-Daily Formulation of AUSTEDO® (deutetrabenazine) Tablets | Business Wire

Teva Pharmaceuticals - News, Articles etc. - European Pharmaceutical Review
Teva Pharmaceuticals - News, Articles etc. - European Pharmaceutical Review

Teva Pharmaceuticals to pay New York $523 million to settle claims from its  role in opioids crisis - ABC News
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News

Teva Pharmaceuticals will pay $420 million in a federal case
Teva Pharmaceuticals will pay $420 million in a federal case

Teva, with a $4.25B opioid settlement in hand, eyes return to growth by  2027 | Fierce Pharma
Teva, with a $4.25B opioid settlement in hand, eyes return to growth by 2027 | Fierce Pharma

Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceuticals is found liable in the opioid crisis : NPR

Teva Pharmaceuticals responsible for fueling opioid crisis, New York jury  finds - JURIST - News
Teva Pharmaceuticals responsible for fueling opioid crisis, New York jury finds - JURIST - News

A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New  York Times
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times

Teva Pharmaceuticals to Pay $225M to Texas to Settle Opioid Epidemic Claims  - Top Class Actions
Teva Pharmaceuticals to Pay $225M to Texas to Settle Opioid Epidemic Claims - Top Class Actions

TEVA News Today | Why did Teva Pharmaceutical Industries stock go down  today?
TEVA News Today | Why did Teva Pharmaceutical Industries stock go down today?

Teva Pharmaceuticals resolves bribery case with Israel authorities | The  FCPA Blog
Teva Pharmaceuticals resolves bribery case with Israel authorities | The FCPA Blog

Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Business -  Haaretz.com
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Business - Haaretz.com

Teva sells Overland Park business segment - Kansas City Business Journal
Teva sells Overland Park business segment - Kansas City Business Journal